Analysts’ Viewpoint
The global asthma monitoring devices market is driven by the growth in prevalence of asthma, development of new & improved asthma monitoring devices, surge in geriatric population, and rise in adoption of advanced monitoring devices such as smart inhalers.
Increase in demand for smart inhalers & telemedicine solutions and government support & reimbursement policies for asthma monitoring devices are offering lucrative opportunities for market players. Manufacturers are focusing on developing connected asthma monitoring devices that allow for real-time monitoring and remote patient monitoring. However, high cost of these devices and lack of reimbursement in some countries are likely to hamper global asthma monitoring devices market growth.
Asthma is an inflammatory disease of the airways to the lungs that makes breathing difficult. Asthma monitoring devices help people with asthma track and manage their condition. These devices can measure various aspects of breathing, such as airflow, and provide real-time information about asthma symptoms and triggers. This information can be used to adjust treatment and avoid asthma attacks.
Prevalence of asthma has increased in the past few years. This has led to a rise in awareness about the need for effective disease management. Increase in investment in research & development activities and advancements in technology have led to introduction of devices that enable remote monitoring of asthma.
Rise in prevalence of asthma and other respiratory conditions is driving the demand for monitoring devices that can help patients manage their symptoms and prevent exacerbations. Asthma monitoring devices such as peak flow meters, spirometers, and wearable devices allow individuals to track their symptoms, monitor lung function, and detect early signs of an asthma attack, which could prompt early intervention and prevent severe outcomes.
According to Asthma and Allergy Foundation of America, asthma is a common chronic respiratory disease that affects millions of people in the U.S. As per the latest data, around 25 million people, or roughly 1 in 13 individuals, have asthma; around 20 million of these are adults aged 18 and older.
In 2019, 44.3% of children under the age of 18 who had asthma reported having at least one asthma attack in the previous year, and 47.2% of children under the age of five who had been diagnosed with asthma had experienced an asthma attack.
Increase in awareness and education about the importance of proper asthma management and monitoring is driving the demand for these devices. Demand for devices that can help track lung function, monitor symptoms, and identify triggers has been rising across the globe. In turn, this is enabling patients to manage asthma more effectively.
The World Health Organization (WHO) is promoting the use of asthma monitoring devices as part of its efforts to ensure universal health coverage. This is being accomplished through various means such as creating guidelines & standards for devices, providing technical support & training to healthcare providers on device usage, and advocating for integration into national health systems. The WHO also collaborates with relevant stakeholders such as manufacturers, health organizations, and governments to ensure that these devices are accessible, affordable, and of high quality.
Based on device type, the smart inhalers segment dominated the global asthma monitoring device market in 2021. This can be ascribed to the ability of smart inhalers to track medication usage, provide real-time monitoring & feedback, and improve medication adherence in patients with asthma.
Integration of smart technology in inhalers has made it easier for healthcare providers to remotely monitor patients and adjust treatment plans as needed, thus leading to better outcomes and increased patient satisfaction.
North America dominated the global market in 2021. Rise in prevalence of asthma, which leads to a high asthma monitoring devices market demand, and access to advanced technology for development of new and innovative asthma monitoring devices are fueling market development in the region.
Well-developed healthcare system that provides easy access to healthcare services and high disposable income, which enables patients to invest in modern healthcare technologies, are fueling market progress in North America. Furthermore, government support and funding for research & development of new asthma monitoring devices is projected to drive market statistics in the region during the forecast period.
The asthma monitoring devices market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. This can be ascribed to the increase in prevalence of asthma & other respiratory conditions, improvement in healthcare infrastructure, and rise in awareness about the importance of monitoring asthma and benefits of using monitoring devices. Governments of countries in the region have launched initiatives to increase access to asthma monitoring devices and spread awareness about the condition. Furthermore, economic growth has led to a rise in disposable income and improvement in access to healthcare in the region.
Europe held significant market share in 2021, led by the increase in prevalence of asthma, technological advancements in devices, and rise in awareness and focus on disease management. Surge in demand for effective and efficient monitoring solutions among asthma patients is expected to augment market dynamics of the region.
This report provides profiles of leading players operating in the global asthma monitoring devices market. These include Medtronic, Koninklijke Philips N.V., GSK plc., F. Hoffmann-La Roche Ltd., ResMed, Siemens, OMRON Corporation, Masimo, Propeller Health, Accumed, Nihon Kohden Corporation, Respira Labs, River City Holdings LLC, and MGC Diagnostics Corporation. These players are engaging in mergers & acquisitions, strategic collaborations, and new product launches to increase their asthma monitoring devices market share.
Leading players have been profiled in the asthma monitoring devices market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 700.0 Mn |
|
Forecast (Value) in 2031 |
More than US$ 1.4 Bn |
|
Growth Rate (CAGR) 2022-2031 |
7.0% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 700.0 Mn in 2021.
It is projected to reach more than US$ 1.4 Bn by 2031.
The CAGR is anticipated to be 7.0% from 2022 to 2031.
The smart inhalers segment accounted for more than 70.0% share in 2021.
North America is expected to account for leading share during the forecast period.
Medtronic, Koninklijke Philips N.V., GSK plc, F. Hoffmann-La Roche Ltd., ResMed, Siemens, OMRON Corporation, Masimo, Propeller Health, Accumed, Respira Labs, Nihon Kohden Corporation, River City Holdings LLC, and MGC Diagnostics Corporation.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Asthma Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Asthma Monitoring Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Regulatory Scenario by Region/globally
5.4. COVID 19 Impact on Industry
6. Global Asthma Monitoring Devices Market Analysis and Forecast, by Device Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Device Type, 2017–2031
6.3.1. Spirometers
6.3.2. Peak Flow Meters
6.3.3. Smart Inhalers
6.3.4. Others
6.4. Market Attractiveness Analysis, by Device Type
7. Global Asthma Monitoring Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals & Clinics
7.3.2. Home Care
7.3.3. Ambulatory Care Centers
7.4. Market Attractiveness Analysis, by End-user
8. Global Asthma Monitoring Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Asthma Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Device Type, 2017–2031
9.2.1. Spirometers
9.2.2. Peak Flow Meters
9.2.3. Smart Inhalers
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Clinics
9.3.2. Home Care
9.3.3. Ambulatory Care Centers
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Device Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Asthma Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Device Type, 2017–2031
10.2.1. Spirometers
10.2.2. Peak Flow Meters
10.2.3. Smart Inhalers
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals & Clinics
10.3.2. Home Care
10.3.3. Ambulatory Care Centers
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Device Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Asthma Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Device Type, 2017–2031
11.2.1. Spirometers
11.2.2. Peak Flow Meters
11.2.3. Smart Inhalers
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals & Clinics
11.3.2. Home Care
11.3.3. Ambulatory Care Centers
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Device Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Asthma Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Device Type, 2017–2031
12.2.1. Spirometers
12.2.2. Peak Flow Meters
12.2.3. Smart Inhalers
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals & Clinics
12.3.2. Home Care
12.3.3. Ambulatory Care Centers
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Device Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Asthma Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Device Type, 2017–2031
13.2.1. Spirometers
13.2.2. Peak Flow Meters
13.2.3. Smart Inhalers
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals & Clinics
13.3.2. Home Care
13.3.3. Ambulatory Care Centers
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Device Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Koninklijke Philips N.V.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. GSK plc
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. F. Hoffmann-La Roche Ltd.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. ResMed
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Siemens
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. OMRON Corporation
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Masimo
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Propeller Health
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Accumed
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Nihon Kohden Corporation
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. River City Holdings LLC
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. MGC Diagnostics Corporation Respira Labs
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.14. Respira Labs
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
List of Tables
Table 01: Global Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 02: Global Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 05: North America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: North America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: Europe Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 08: Europe Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Asia Pacific Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 11: Asia Pacific Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Asia Pacific Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Latin America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 14: Latin America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Latin America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Middle East & Africa Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 17: Middle East & Africa Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Middle East & Africa Asthma Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 03: Global Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 04: Global Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 05: Global Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 06: Global Asthma Monitoring Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 07: Global Asthma Monitoring Devices Market Attractiveness Analysis, by Region, 2022–2031
Figure 08: North America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 09: North America Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 10: North America Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 11: North America Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 12: North America Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 13: North America Asthma Monitoring Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 14: North America Asthma Monitoring Devices Market Attractiveness Analysis, by Country, 2022–2031
Figure 15: Europe Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 16: Europe Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 17: Europe Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 18: Europe Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 19: Europe Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 20: Europe Asthma Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 21: Europe Asthma Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 22: Asia Pacific Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: Asia Pacific Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 24: Asia Pacific Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 25: Asia Pacific Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 26: Asia Pacific Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 27: Asia Pacific Asthma Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 28: Asia Pacific Asthma Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 29: Latin America Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: Latin America Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 31: Latin America Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 32: Latin America Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 33: Latin America Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 34: Latin America Asthma Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 35: Latin America Asthma Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 36: Middle East & Africa Asthma Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Middle East & Africa Asthma Monitoring Devices Market Value Share Analysis, by Device Type, 2021 and 2031
Figure 38: Middle East & Africa Asthma Monitoring Devices Market Attractiveness Analysis, by Device Type, 2022–2031
Figure 39: Middle East & Africa Asthma Monitoring Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Middle East & Africa Asthma Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 41: Middle East & Africa Asthma Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Middle East & Africa Asthma Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 43: Global Asthma Monitoring Devices Market Share Analysis, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Asthma Monitoring Devices Market
